Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Molecules. 2017 Jun 1;22(6):E917. doi: 10.3390/molecules22060917

Figure 5.

Figure 5

The progression from xanthines, such as caffeine, to the novel compound istradefylline, which was recently approved for the use in Parkinson’s diseases.